The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
Jun. 01, 2022
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Dominik Feuerbach, Basel, CH;
Baltazar Gomez-Mancilla, Basel, CH;
Yunsheng He, Cambridge, MA (US);
Donald Johns, Cambridge, MA (US);
Cristina Lopez-Lopez, Basel, CH;
Kevin Hall McAllister, Basel, CH;
Nicole Pezous, Basel, CH;
Lisa Sandford, Basel, CH;
Markus Weiss, Basel, CH;
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); A61K 9/20 (2006.01); A61K 31/439 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01); C12Q 1/6883 (2018.01); A61K 9/16 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2086 (2013.01); A61K 31/439 (2013.01); A61K 31/444 (2013.01); A61K 45/06 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 2300/00 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); C12Q 2600/172 (2013.01);
Abstract
The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment.